Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Comprehensive Therapy
Erschienen in: Comprehensive Therapy 2/2007

01.06.2007 | Original Article

Cardiovascular Manifestations Seen in Obstructive Sleep Apnea

verfasst von: Wilbert S. Aronow

Erschienen in: Comprehensive Therapy | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

Patients with obstructive sleep apnea (OSA) have an increased prevalence of systemic and pulmonary hypertension, left ventricular (LV) hypertrophy, LV systolic and diastolic dysfunction, and congestive heart failure, increased platelet aggregability, and increased susceptibility to thrombotic and embolic cardiac and cerebrovascular events. Patients with OSA have an increased prevalence of coronary artery disease, myocardial infarction, nocturnal angina, and myocardial ischemia, arrhythmias, and sudden cardiac death. Patients with OSA also have an increased prevalence of stroke. Treatment of OSA with continuous positive airway pressure improves cardiac efficiency in patients with heart failure, causes a reduction in the frequency of nocturnal ischemic ST-segment depression, relieves nocturnal angina, and causes a reduction in the occurrence of new cardiovascular events and an increase in the time to such events.
Literatur
1.
Hudgel DW. Variable site of airway narrowing among obstructive sleep apnea patients. J Appl Physiol 1986;61:1403–9.PubMed
2.
Ziegler MG, Nelesen R, Mills P, et al. Sleep apnea, norepnephrine-release rate, and daytime hypertension. Sleep 1997;20:224–31.PubMed
3.
Anand A, Sailor S, Launois SH, et al. Peripheral vascular resistance increases after termination of obstructive sleep apnea. J Appl Physiol 2001;91:2359–65.PubMed
4.
Smith M, Neidermaier O, Hardy S, et al. Role of hypoxemia in sleep apnea-induced sympathoexcitation. J Auton Nerv Syst 1996;56:184–90.PubMedCrossRef
5.
Kraiczi H, Hender J, Peker Y, et al. Increased vasoconstrictor sensitivity in obstructive sleep apnea. J Appl Physiol 2000;89:493–8.PubMed
6.
Allen DG, Orchard CH. Myocardial contractile function during ischemia and hypoxia. Circ Res 1987;60:153–68.PubMed
7.
Shepard JW. Cardiopulmonary consequences of obstructive sleep apnea. Mayo Clin Proc 1990;65:1250–9.PubMed
8.
Sajkov D, Cowie RJ, Thornton AT. Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1994;149:416–22.PubMed
9.
Schneider H, Schaub CD, Chen CA, et al. Neural and local effects of hypoxia on cardiovascular responses to obstructive apnea. J Appl Physiol 2000;88:1093–102.PubMed
10.
Schneider H, Schaub CD, Andreoni AR, et al. Systemic and pulmonary hemodynamic responses to normal and obstructed breathing during sleep. J Appl Physiol 1997;83:1671–80.PubMed
11.
Leung RST, Bradley TD. Sleep apnea and cardiovascular disease. Am J Respir Cirt Care Med 2001;164:2147–65.
12.
Sidana J, Aronow WS, Ravipati G, et al. Prevalence of moderate or severe left ventricular diastolic dysfunction in obese persons with obstructive sleep apnea. Cardiology 2005;104:107–9.PubMedCrossRef
13.
Bradley TD, Floras JS. Sleep apnea and heart failure. I. Obstructive sleep apnea. Circulation 2003;107:1671–8.PubMedCrossRef
14.
Bradley TD, Floras JS. Sleep apnea and heart failure. II. Central sleep apnea. Circulation 2003;107:1822–6.PubMedCrossRef
15.
Hia KM, Young TB, Bidwell T, et al. Sleep apnea and hypertension. A population based study. Ann Intern Med 1994 ;120:382–8.
16.
Young T, Peppard P, Palta M, et al. Population-based study of sleep-disordered breathing as a risk factor of hypertension. Arch Intern Med 1997;157:1746–52.PubMedCrossRef
17.
Haas DC, Foster GL, Nieto J, et al. Age-dependent associations between sleep-disordered breathing and hypertension. Importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation 2005;111:614–21.PubMedCrossRef
18.
Narkiewicz K, Van de Born PJ, Pesek CA, et al. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 1999;99:1183–9.PubMed
19.
Hender JA, Wilcox I, Laks L, et al. A specific and potent pressor effect of hypoxia in patients with sleep apnea. Am Rev Respir Dis 1992;146:1240–5.
20.
Bonsignore MR, Marrone O, Insalaco G, et al. The cardiovascular effects of obstructive sleep apneas: analysis of pathogenic mechanisms. Eur Respir J 1994;7:786–805.PubMedCrossRef
21.
Sajkov D, Wang T, Saunders NA, et al. Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease. Am Rev Respir Crit Care Med 1999;159:1518–26.
22.
Cloward TV, Walker JM, Farney RJ, et al. Left ventricular hypertrophy is a common echocardiographic abnormality in severe obstructive sleep apnea and reverses with nasal continuous positive airway pressure. Chest 2003;124:594–601.PubMedCrossRef
23.
Noda A, Okada T, Yasuma F, et al. Cardiac hypertrophy in obstructive sleep apnea syndrome. Chest 1995;107:1538–44.PubMed
24.
Sukhija R, Aronow WS, Sandhu R, et al. Prevalence of left ventricular hypertrophy in persons with and without obstructive sleep apnea. Cardiol Rev 2006;14:170–2.PubMedCrossRef
25.
Aronow WS. Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure. Cardiol Rev 2006;14:108–24.PubMedCrossRef
26.
Javaheri S. A mechanism of central sleep apnea in patients with heart failure. N Eng J Med 1999;341:949–54.CrossRef
27.
Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease. Cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19–25.PubMed
28.
Chan J, Sanderson J, Chan W, et al. Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction. Chest 1997;111:1488–93.PubMed
29.
Fung JWH, Li TST, Choy DKL, et al. Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction. Chest 2002;121:422–9.PubMedCrossRef
30.
Yoshinaga K, Burwash IG, Leech JA, et al. The effects of continuous positive airway pressure on myocardial energetics in patients with heart failure and obstructive sleep apnea. J Am Coll Cardiol 2007;49:450–8.PubMedCrossRef
31.
Hung J, Whitford EG, Parsons RW, et al. Association of sleep apnea with myocardial infarction in men. Lancet 1990;336:261–4.PubMedCrossRef
32.
Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnea: a long-term follow-up. Eur Respir J 2006;28:596–602.PubMedCrossRef
33.
Schafer H, Koehler U, Ewig S, et al. Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology 1999;92:79–84.PubMedCrossRef
34.
Sandhu R, Aronow WS, Mehta N, et al. Prevalence of ≥1-vessel obstructive coronary artery disease and of 3-vessel obstructive coronary artery disease in patients with moderate or severe obstructive sleep apnea versus mild or no obstructive sleep apnea. Int J Angiol 2007;15:177–8.
35.
Peled N, Abinader EG, Pillar G, et al. Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive airway pressure treatment. J Am Coll Cardiol 1999;34:1744–9.PubMedCrossRef
36.
Philip P, Guilleminault C. ST segment abnormality, angina during sleep and obstructive sleep apnea. Sleep 1993;16:558–9.PubMed
37.
Alonso-Fernandez A, Garcia-Rio F, Racionero MA, et al. Cardiac rhythm disturbances and ST-segment depression episodes in patients with obstructive sleep apnea-hypopnea syndrome and its mechanisms. Chest 2005;127:15–22.PubMedCrossRef
38.
Hayashi M, Fujimoto K, Urushibata K, et al. Nocturnal oxygen desaturation correlates with the severity of coronary atherosclerosis in coronary artery disease. Chest 2003;124:936–41.PubMedCrossRef
39.
Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005;352:1206–14.PubMedCrossRef
40.
Milleron O, Pilliere R, Foucher A, et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 2004;25:709–11.CrossRef
41.
Can M, Acikgoz S, Mungan G, et al. Serum cardiovascular risk factors in obstructive sleep apnea. Chest 2006;129:233–7.PubMedCrossRef
42.
Koehler U, Fus E, Grimm W. Heart block in patients with obstructive sleep apnea: pathogenetic factors and effects of treatment. Eur Respir J 1998;11:434–9.PubMedCrossRef
43.
Harbison J, Philip O, McNicholas WT. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effect of nasal continuous positive airway pressure. Chest 2000;118:591–5.PubMedCrossRef
44.
Javaheri S. Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 2000;101:392–7.PubMed
45.
Gami AS, Hodge DO, Herges RM, et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 2007;49:565–71.PubMedCrossRef
46.
Guilleminault C, Connoly S, Winkle R. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983;52:490–4.PubMedCrossRef
47.
Neau J, Meurice J, Paquereau J, et al. Habitual snoring as a risk factor for brain infarction. Acta Neurol Scand 1995;92:63–8.PubMedCrossRef
48.
Palomaki H. Snoring and the risk of ischemic brain infarction. Stroke 1991;22:1021–5.PubMed
49.
Yaggi HK, Concatro J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005;353:2034–41.PubMedCrossRef
50.
Roux F, D’Ambrosio C, Mohsenin V. Sleep-related breathing disorders and cardiovascular disease. Am J Med 2000;108:396–402.PubMedCrossRef
51.
Balfors EM, Franklin KA. Impairment of cerebral perfusion during obstructive sleep apneas. Am J Respir Crit Care Med 1994;150:1587–91.PubMed
52.
Bokinsky G, Miller M, Ault K, et al. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy. Chest 1995;108:625–30.PubMed
53.
Goldstein LB, Adams R, Alberts MJ, et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Stroke 2006;37:1583–633.PubMed
Metadaten
Titel
Cardiovascular Manifestations Seen in Obstructive Sleep Apnea
verfasst von
Wilbert S. Aronow
Publikationsdatum
01.06.2007
Verlag
Humana Press Inc
Erschienen in
Comprehensive Therapy / Ausgabe 2/2007
Print ISSN: 0098-8243
Elektronische ISSN: 1559-1190
DOI
https://doi.org/10.1007/s12019-007-8004-9

Weitere Artikel der Ausgabe 2/2007

Comprehensive Therapy 2/2007 Zur Ausgabe

Original Article

Submicrobial Doxycycline and Rosacea

CME Questions

CME Questions

Case Report

Conjunctival Pigmentation in Stevens–Johnson Syndrome

Editorial

Editorial

Original Article

Hepatitis C: Epidemiology, Diagnosis, and Management

Editor’s Preface

Alkaptonuria Presenting with Conjunctival Lesion